KAKazumori Arai

Kazumori Arai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kazumori Arai has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Male Patients With β ‐Catenin‐Positive Atypical Hepatocellular Neoplasm Arising in Inflammatory Hepatocellular Adenoma: A Case Report

    by Shingo Yamasaki, Akihiko Takagi, Daisuke Yamamoto, Ryuta Muraki, Satoshi Tokuda, Takeo Toda, Makoto Obayashi, Kazumori Arai, Hideyuki Kanemoto

    Hepatocellular adenoma (HCA) is a benign tumor that predominantly occurs in young female, whereas male sex is considered a risk factor for malignant transformation. Recent studies from Asian countries have reported a different sex distribution pattern. However, there are few reports of HCA in Japan. We report a case of a male patient, diagnosed with inflammatory HCA (IHCA) including small areas of atypical hepatocellular neoplasm. A 66‐year‐old man was found to have a 6 cm tumor protruding extrahepatically from segment 6 (S6) of the liver on imaging. Differential diagnoses included focal nodular hyperplasia (FNH), HCA, hemangioma, and did not exclude hepatocellular carcinoma (HCC). Due to the risk of rupture, laparoscopic partial hepatectomy of S6 was performed. Although there was a lack of consensus among experts regarding the diagnosis, histological and immunohistochemical analyses led to a diagnosis of IHCA with small areas of β ‐catenin‐positive atypical hepatocellular neoplasm.

  • Open Access

    Involvement of Membranous S100A10 Expression in the Tumor Budding of Colorectal Cancer: An Immunohistochemical Study

    by Kazumori Arai, Akikazu Endo, Kensuke Shimazaki, Akihiro Sonoda, Koji Takahashi, Tomohiro Iwasaki, Junichi Sakane

    Tumor budding (TB) in colorectal cancer (CRC) has been associated with poor prognosis. TB has been considered a form of epithelial–mesenchymal transition (EMT). Additional discovery of proteins involved in TB can help suppress the aggressiveness of CRC. This study focused on examining whether S100A10, which has been implicated in TB and EMT, qualifies as a biomarker for TB. Formalin-fixed, paraffin-embedded tissue sections from 339 low-grade adenocarcinomas were used. TB was assessed using the recommended hotspot method. Immunohistochemical analysis focused on S100A10 expression on both the tumor buds at the hotspot and tumor glands (TGs), which serve as the direct background for TB, with the stroma-facing membrane (SFM) being the target for the evaluation. Among the 339 patients analyzed, 190 (56.0%) were confirmed to have TB. S100A10 positivity in the tumor buds was detected in 153 patients (80.5%) and was significantly correlated with high-grade TB and high S100A10 positivity in background TGs. S100A10 positivity in background TGs was significantly correlated with high-grade TB, node metastasis, and poor pStage. S100A10 positivity in TGs was often observed in the portions having an irregular border with the stroma, especially ones protruding toward the stroma. In CRC, S100A10 expression at the SFMs of the TGs likely promotes TB from its earliest stage and remains active during TB. The increase in the number of S100A10-expressing tumor cells was associated with poor biological behavior in CRC. Overall, our findings suggest that S100A10 could be a potential biomarker for TB of CRC.

  • Re-evaluation of histopathological factors for the outcome of salivary duct carcinoma patients: A multi-institutional retrospective study of 240 cases in a Japanese cohort

    by Kimihide Kusafuka, Eiji Nakatani, Satoshi Baba, Yoshifumi Arai, Matsuyoshi Maeda, Koji Yamanegi, Takayuki Murase, Hiroshi Inagaki, Yoshiro Otsuki, Kensuke Suzuki, et al.


  • Open Access

    Relevance of Immunohistochemistry for Tumorigenic Tumor‐Infiltrating Neutrophils and Reverse Polarity in Colonic Micropapillary Adenocarcinoma: A Case Report

    by Kazumori Arai, Kensuke Shimazaki, Koji Takahashi, Hiroyuki Hazama, Ko Ohata, Akihiro Sonoda, Tomohiro Iwasaki, Junichi Sakane

    Similar to that in other organs, colorectal micropapillary adenocarcinoma (MPA) shows aggressive biological characteristics and reverse polarity (RP). Inhibiting the RP may reduce cancer aggressiveness; however, the pathogenesis of RP remains unclear. We encountered a case of colorectal MPA with tumor‐infiltrating neutrophils (TINs), which were suspected to be involved in micropapillary morphogenesis. We examined the case using immunohistochemistry, including luminal differentiation (LD) markers. Numerous TINs were found within the background MPA tumor components, and there were scattered tumor cell detachments from the stroma and disruption of glandular structures. Furthermore, the ruptured lumens were connected to the lacunar stromal spaces created by the tumor cell detachment, and floating isolated tumor cell clusters were observed. Immunohistochemistry suggested that most of the TINs had immunosuppressive and tumor‐promoting properties and that the tumor cells that have lost adhesion to the stroma and/or intercellular contacts acquired new LD. Such tumor cell changes have been observed in our previous report on tumors with frequent apoptosis. Based on this case, we suggested that (1) the essence of RP in MPA comprises new LD/apical polarity in tumor cells, which have lost glandular polarity secondary to exfoliative and destructive changes, and (2) the cause of RP might be multifactorial.

  • S100A8 and S100A9 are associated with endometrial shedding during menstruation

    by Kazumori Arai, Aki Kubota, Tomohiro Iwasaki, Akihiro Sonoda, Junichi Sakane

    Matrix metalloproteinases (MMPs) and their major source, endometrial stromal cells (ESCs), play important roles in menstruation. However, other mechanisms in endometrial shedding may be unexplored. This study focused on four proteins: S100A8 and S100A9 (alarmins) are binding partners and induce MMPs, MMP-3 cycle-dependently plays a key role in the proteolytic cascade, and CD147, which has S100A9 as its ligand, induces MMPs. Immunostaining for these proteins was performed on 118 resected specimens. The percentage and location of each positive reaction in ESCs were measured and compared using Image J. The influence of leukocytes on S100A8 or S100A9 immunopositivity was also examined. From the premenstrual phase, S100A8 and MMP-3 began to have overlapping expressions in ESCs of the superficial layer, and ESC detachment was found within these sites. S100A9 was expressed from the late secretory phase and CD147 already from earlier. Later, the expression sites of S100A9 and CD147 included those of S100A8. Before menstruation, S100A8 or S100A9 expression was not affected by leukocytes. These results suggest that the local formation of S100A8/S100A9 complex, which occurs specifically in ESCs upon progesterone withdrawal, induces the local expression of MMP-3 and serves as a switch to the lysis phase.

  • A symptomatic intercalated duct lesion of the parotid gland: a case report with immunohistochemical and genetic analyses

    by Kimihide Kusafuka, Satoshi Baba, Yoshiharu Kitani, Kazuki Hirata, Akinori Murakami, Aya Muramatsu, Kazumori Arai, Makoto Suzuki

    Intercalated duct lesions (IDLs) are usually asymptomatic. We report a case of IDL, in which a palpable mass formed. The patient was a 45-year-old Japanese male, who noticed a mass in the left parotid region. The nodular lesion was well-circumscribed, but did not have a fibrous capsule or exhibit infiltrative growth. It contained a small cystic space and consisted of basaloid cells arranged in a cribriform pattern and inner ductal cells. It had some solid areas of nest-like proliferation displaying mild cellular atypia. Immunohistochemically, the luminal cells were positive for cytokeratin (CK)7 and epithelial membrane antigen, and the abluminal cells were positive for CK5/6, p63, and DOG1. S-100 protein-positive stromal cells were also seen. The lesion’s cells were all positive for SOX10, and the nuclei of some basaloid cells were positive for β-catenin. The Ki-67 labeling index was 3.8%. The ductal cells contained diastase-digestion-resistant, Periodic acid Schiff-positive zymogen granules. Genetically, the lesion harbored a missense mutation in the CTNNB1 gene. We diagnosed the lesion as an IDL. As IDLs are usually small non-neoplastic lesions, symptomatic cases are rare. Based on its common immunohistochemical and genetic features, IDL may be a precursor of basal cell adenoma/adenocarcinoma, such as intercalated duct adenoma.


  • Open Access

    Nivolumab‐induced liver injury with a steroid‐refractory increase in biliary enzymes, in a patient with malignant mesothelioma: An autopsy case report

    by Kazumori Arai, Masanori Matsuda, Hiromasa Nakayasu, Shiori Meguro, Takafumi Kurokami, Aki Kubota, Tomohiro Iwasaki, Makoto Suzuki, Shinya Kawaguchi, Toshihide Iwashita

    This is the first autopsy report of hepatotoxicity from nivolumab immunotherapy for malignant mesothelioma. The increase in levels of biliary enzymes and randomly distributed endothelial damage were steroid‐refractory, but second‐line option was abandoned because of cachexia. Further discussions are needed regarding the customized management of immune‐related toxicities.


  • Open Access

    Periostin expression and its supposed roles in benign and malignant thyroid nodules: an immunohistochemical study of 105 cases

    by Kimihide Kusafuka, Masaru Yamashita, Tomohiro Iwasaki, Chinatsu Tsuchiya, Aki Kubota, Kazuki Hirata, Akinori Murakami, Aya Muramatsu, Kazumori Arai, Makoto Suzuki

    Background: Thyroid tumors are often difficult to histopathologically diagnose, particularly follicular adenoma (FA) and follicular carcinoma (FC). Papillary carcinoma (PAC) has several histological subtypes. Periostin (PON), which is a non-collagenous extracellular matrix molecule, has been implicated in tumor invasiveness. We herein aimed to elucidate the expression status and localization of PON in thyroid tumors. Method: We collected 105 cases of thyroid nodules, which included cases of adenomatous goiter, FA, microcarcinoma (MIC), PAC, FC, poorly differentiated carcinoma (PDCa), and undifferentiated carcinoma (UCa), and immunohistochemically examined the PON expression patterns of these lesions. Results: Stromal PON deposition was detected in PAC and MIC, particularly in the solid/sclerosing subtype, whereas FA and FC showed weak deposition on the fibrous capsule. However, the invasive and/or extracapsular regions of microinvasive FC showed quite strong PON expression. Except for it, we could not find any significant histopathological differences between FA and FC. There were no other significant histopathological differences between FA and FC. Although PDCa showed a similar PON expression pattern to PAC, UCa exhibited stromal PON deposition in its invasive portions and cytoplasmic expression in its carcinoma cells. Although there was only one case of UCa, it showed strong PON immunopositivity. PAC and MIC showed similar patterns of stromal PON deposition, particularly at the invasive front. Conclusions: PON may play a role in the invasion of thyroid carcinomas, particularly PAC and UCa, whereas it may act as a barrier to the growth of tumor cells in FA and minimally invasive FC.


  • A Case of Colonic Micropapillary Carcinoma with a High Frequency of Apoptosis

    by Kazumori Arai, Tomohiro Iwasaki, Hisato Ishimatsu, Chinatsu Tsuchiya, Aki Kubota, Akihiro Sonoda, Ko Ohata

    Colorectal micropapillary carcinoma (MPC) exhibits aggressive biological characteristics, with empty spaces and reversed polarity, similar to the poorly differentiated clusters (PDCs) formed from detached cancer cells. Epithelial–mesenchymal transition, which is involved in the cancer cell acquisition of apoptosis resistance, is closely linked with histological findings of MPC, PDCs, and tumor buds (TBs), with MPC and TBs considered as apoptosis-resistant features. However, we encountered a case of colonic MPC with frequent apoptosis. We examined the case using immunohistochemistry. In many of the tumor glands (TGs) of the MPC, empty spaces and tumor cell detachment toward the gland interior were observed. Moreover, TG ruptures were scattered, with PDCs adjacent to them. Apoptosis occurred mainly at the TG and PDC peripheries in the middle and deep tumor layers, and transforming growth factor beta 1 (TGF-β1) positivity was evident in those tumor cells. Cells positive for apoptosis-related M30 were distributed mainly in the deep layer with a significant PDC and TB presence. However, apoptosis and M30 positivity were low in the TBs. Non-tumorous bud components, especially those in the deep layer, had poor ability to promptly acquire apoptosis resistance. No nuclear β-catenin positivity was found in any of the tumor cells. Apoptosis has the potential to reciprocally produce MPC, PDCs, and TBs, with TGF-β1 involvement.


  • Open Access

    A Case of Colonic Micropapillary Carcinoma With a High Frequency of Apoptosis

    by Kazumori Arai, Tomohiro Iwasaki, Hisato Ishimatsu, Chinatsu Tsuchiya, Aki Kubota, Akihiro Sonoda, Ko Ohata

    Purpose: Colorectal micropapillary carcinoma (MPC) exhibits aggressive biological characteristics, with empty spaces and reversed polarity, similar to the poorly differentiated clusters (PDCs) formed from detached cancer cells. Epithelial–mesenchymal transition, which is involved in the cancer cell acquisition of apoptosis resistance, is closely linked with histological findings of MPC, PDCs, and tumor buds (TBs), with MPC and TBs considered as apoptosis-resistant features. However, we encountered a case of colonic MPC with frequent apoptosis.Methods: We examined the case using immunohistochemistry and compared it with two cases of conventional colonic cancer with high PDC and TB presence.Results: In many of the tumor glands (TGs) of the MPC, empty spaces and tumor cell detachment toward the gland interior were observed. Moreover, TG ruptures were scattered, with PDCs adjacent to them. Apoptosis occurred mainly at the TG and PDC peripheries in the middle and deep tumor layers, and transforming growth factor beta 1 (TGF-β1) positivity was evident in those tumor cells. Cells positive for apoptosis-related M30 were distributed mainly in the deep layer with a significant PDC and TB presence. However, apoptosis and M30 positivity were low in the TBs. In the control cases, apoptosis hardly occurred. Furthermore, M30 positivity in the TGs was scattered and barely evident in the PDCs. Aberrant β-catenin positivity was found. In MPC, non-tumorous bud components, especially those in the deep layer, had poor abilities to promptly acquire apoptosis resistance. Conclusion: Apoptosis has the potential to reciprocally produce MPC, PDCs, and TBs, with TGF-β1 involvement.